As of June 2024 Novanta has a market cap of $5.89 Billion. This makes Novanta the world's 2383th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Year | Market cap | Change |
---|---|---|
2024 | $5.89 B | -2.2% |
2023 | $6.03 B | 24.37% |
2022 | $4.84 B | -22.75% |
2021 | $6.27 B | 51.02% |
2020 | $4.15 B | 34.09% |
2019 | $3.09 B | 41.05% |
2018 | $2.19 B | 27.07% |
2017 | $1.72 B | 139.12% |
2016 | $0.72 B | 54.63% |
2015 | $0.46 B | -7.13% |
2014 | $0.50 B | 31.84% |
2013 | $0.38 B | 30.54% |
2012 | $0.29 B | -14.26% |
2011 | $0.34 B | -3.24% |
2010 | $0.35 B |
On Jun 17th, 2024 the market cap of Novanta was reported to be:
Name | Market cap | Market cap differencediff. | Country |
---|---|---|---|
PAVmed
PAVM | $9.52 M | -99.84% | ๐บ๐ธ USA |
Philips PHG | $24.26 B | 311.42% | ๐ณ๐ฑ Netherlands |